C2ORF66 抗体 (AA 51-117)
Quick Overview for C2ORF66 抗体 (AA 51-117) (ABIN2171435)
抗原
适用
宿主
克隆类型
应用范围
- 
    - 
                                            抗原表位
- AA 51-117
- 
                                            预测反应
- Human,Rat,Sheep,Horse,Rabbit
- 
                                            纯化方法
- Purified by Protein A.
- 
                                            免疫原
- KLH conjugated synthetic peptide derived from human C2orf66
- 
                                            亚型
- IgG
 
- 
                                            
- 
    - 
                                            应用备注
- 
                        WB 1:300-5000
 ELISA 1:500-1000
 IHC-P 1:200-400
 IHC-F 1:100-500
 IF(IHC-P) 1:50-200
 IF(IHC-F) 1:50-200
 IF(ICC) 1:50-200
 ICC 1:100-500
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 1 μg/μL
- 
                                            缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - C2ORF66 (Chromosome 2 Open Reading Frame 66 (C2ORF66))
- 
                                            别名
- C2orf66
- 
                                            背景
- 
                        Synonyms: C2orf66, CB066_HUMAN, Uncharacterized protein C2orf66. Background: C2orf66 
 抗原
- 
                    
 
                                     
                                     
                                    